Rathbones Group’s Oramed Pharmaceuticals ORMP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $524K | Sell |
233,018
-3,785
| -2% | -$8.52K | ﹤0.01% | 425 |
|
|
2025
Q1 | $507K | Sell |
236,803
-53,000
| -18% | -$113K | ﹤0.01% | 410 |
|
|
2024
Q4 | $701K | Hold |
289,803
| – | – | ﹤0.01% | 370 |
|
|
2024
Q3 | $707K | Hold |
289,803
| – | – | ﹤0.01% | 367 |
|
|
2024
Q2 | $745K | Hold |
289,803
| – | – | ﹤0.01% | 358 |
|
|
2024
Q1 | $846K | Hold |
289,803
| – | – | ﹤0.01% | 345 |
|
|
2023
Q4 | $669K | Hold |
289,803
| – | – | ﹤0.01% | 355 |
|
|
2023
Q3 | $756K | Buy |
+289,803
| New | +$756K | 0.01% | 343 |
|